Approval · Notice of Compliance 19188 · 2017
ERIVEDGE: Notice of Compliance 19188
Issued April 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19188
- Date
- April 21, 2017
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph based on findings from a post-approval phase II study (steevie)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERIVEDGE | Not yet assigned | — |
Medicinal ingredients
- VISMODEGIB 150 MG per CAP